Wesana Health Holdings Inc. (WSNAF)
USD 0.04
(135.29%)
USD 0.04
(135.29%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.75 Million USD | 79.59% |
| 2022 | -8.59 Million USD | 74.96% |
| 2021 | -34.33 Million USD | -39288.3% |
| 2020 | -87.18 Thousand USD | 14.13% |
| 2019 | -101.53 Thousand USD | -152.64% |
| 2018 | -40.18 Thousand USD | 0.0% |
| 2015 | -197.94 Thousand USD | 78.9% |
| 2014 | -938.36 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -210.96 Thousand USD | 71.5% |
| 2024 Q2 | -196.14 Thousand USD | 7.01% |
| 2023 FY | -1.75 Million USD | 79.59% |
| 2023 Q4 | -740.21 Thousand USD | -218.1% |
| 2023 Q1 | -654.81 Thousand USD | 49.78% |
| 2023 Q2 | -945.21 Thousand USD | -44.35% |
| 2023 Q3 | 626.76 Thousand USD | 166.31% |
| 2022 FY | -8.59 Million USD | 74.96% |
| 2022 Q4 | -1.3 Million USD | -693.77% |
| 2022 Q3 | 219.59 Thousand USD | 108.24% |
| 2022 Q2 | -2.66 Million USD | 45.09% |
| 2022 Q1 | -4.85 Million USD | 78.63% |
| 2021 Q3 | -4.17 Million USD | 15.03% |
| 2021 FY | -34.33 Million USD | -39288.3% |
| 2021 Q4 | -22.71 Million USD | -444.16% |
| 2021 Q1 | -2.54 Million USD | -4867.55% |
| 2021 Q2 | -4.91 Million USD | -93.29% |
| 2020 Q1 | -468.00 USD | 0.0% |
| 2020 Q4 | -51.15 Thousand USD | -81.68% |
| 2020 Q3 | -28.15 Thousand USD | -280.38% |
| 2020 Q2 | -7402.00 USD | -1481.62% |
| 2020 FY | -87.18 Thousand USD | 14.13% |
| 2019 FY | -101.53 Thousand USD | -152.64% |
| 2018 FY | -40.18 Thousand USD | 0.0% |
| 2015 FY | -197.94 Thousand USD | 78.9% |
| 2014 FY | -938.36 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -31.401% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 74.87% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 103.312% |
| Nascent Biotech, Inc. | -2.08 Million USD | 15.946% |
| Rebus Holdings, Inc. | -1.02 Million USD | -72.036% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 102.694% |
| Qrons Inc. | -789.34 Thousand USD | -122.307% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -177.475% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 97.197% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -322.349% |
| Skye Bioscience, Inc. | -37.64 Million USD | 95.339% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 97.659% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 73.316% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -541.828% |
| SQZ Biotechnologies Company | -79.46 Million USD | 97.792% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | 39.332% |
| Propanc Biopharma, Inc. | -1.82 Million USD | 3.612% |
| Mesoblast Limited | -87.95 Million USD | 98.005% |
| Marizyme, Inc. | -65.34 Million USD | 97.315% |
| Genus plc | 7.9 Million USD | 122.212% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 83.889% |
| Pharming Group N.V. | -10.54 Million USD | 83.364% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | 19.128% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 52.705% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 80.159% |
| ContraFect Corporation | -65.15 Million USD | 97.307% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 64.086% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -1.581% |
| IMV Inc. | -36.48 Million USD | 95.191% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 78.228% |
| MultiCell Technologies, Inc. | -380.07 USD | -461596.793% |
| ONE Bio Corp. | 8.67 Million USD | 120.224% |
| Accustem Sciences Inc. | -3.74 Million USD | 53.161% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 96.605% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -38.483% |
| Q BioMed Inc. | -2.05 Million USD | 14.489% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 52.993% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | 26.297% |
| Biomind Labs Inc. | -1.21 Million USD | -44.507% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 97.062% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 43.427% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 77.796% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | 9.977% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -11617.221% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 88.944% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 69.835% |
| GB Sciences, Inc. | -1.36 Million USD | -28.868% |
| Alpha Cognition Inc. | -13.77 Million USD | 87.259% |
| HST Global, Inc. | -146.21 Thousand USD | -1100.172% |
| CSL Limited | 2.64 Billion USD | 100.066% |
| Halberd Corporation | -79.67 Thousand USD | -2102.383% |
| Enzolytics Inc. | -2.17 Million USD | 19.389% |
| Agentix Corp. | -1.37 Million USD | -27.693% |
| Resverlogix Corp. | -3.61 Million USD | 51.391% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 44.67% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 99.405% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 1890.583% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 125.341% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 55.833% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 42.013% |
| AVAX Technologies, Inc. | -6.41 Million USD | 72.64% |
| Zenith Capital Corp. | -10.59 Million USD | 83.439% |
| Genscript Biotech Corporation | -95.47 Million USD | 98.162% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -7450.0% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 57.675% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -2803.298% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 12.485% |
| Kadimastem Ltd | -3.3 Million USD | 46.944% |
| Helix BioMedix, Inc. | -1.05 Million USD | -66.163% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 54.052% |
| BioStem Technologies, Inc. | -8.48 Million USD | 79.314% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -297.575% |
| LadRx Corporation | 400.44 Thousand USD | 538.207% |
| Cell Source, Inc. | -5.32 Million USD | 67.023% |
| Regen BioPharma, Inc. | 1.02 Million USD | 271.447% |
| Regen BioPharma, Inc. | 1.02 Million USD | 271.447% |
| NovAccess Global Inc. | -4.76 Million USD | 63.206% |
| Affymax, Inc. | -14.42 Million USD | 87.834% |
| Itoco Inc. | -1.86 Million USD | 6.112% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 60.501% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -5.139% |
| Mobile Lads Corp. | -2.26 Million USD | 22.468% |
| CytoDyn Inc. | -49.84 Million USD | 96.479% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -2120.302% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -669.208% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -86.375% |
| SYBLEU INC | -180.3 Thousand USD | -873.229% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -8.807% |
| International Stem Cell Corporation | -131 Thousand USD | -1239.52% |
| Bioxytran, Inc. | -4.28 Million USD | 59.001% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -3133.29% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | 30.648% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 96.35% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | 16.993% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -124.715% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 44.61% |
| Neutra Corp. | -233.46 Thousand USD | -651.621% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 91.352% |
| PureTech Health plc | -65.69 Million USD | 97.329% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 91.749% |
| IXICO plc | -1.17 Million USD | -48.962% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 82.323% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 96.928% |
| CSL Limited | 2.64 Billion USD | 100.066% |
| Cellectis S.A. | -103.17 Million USD | 98.299% |